C3GN and ANCA Vasculitis Scientific Symposium
The C3GN and ANCA Vasculitis Scientific Symposium will bring together nationally recognized experts and multidisciplinary faculty from UCLA to advance clinical understanding, foster collaboration, and lay the foundation for a dedicated, comprehensive program at UCLA focused on these complex and rare kidney diseases.
The symposium will feature leading national experts in ANCA-associated vasculitis and C3 glomerulopathy, alongside UCLA faculty leaders representing relevant specialties, including nephrology, rheumatology, pathology, pulmonology, and other disciplines involved in the diagnosis and management of these conditions. Through expert presentations, multidisciplinary case discussions, and collaborative dialogue, the program will explore advances in disease mechanisms, diagnostic approaches, emerging therapies, and coordinated, patient-centered care.
Beyond education and scientific exchange, a central goal of the symposium is to bring together the expertise and institutional leadership needed to establish a dedicated UCLA program for ANCA vasculitis and C3 glomerulopathy. By engaging nationally recognized faculty and leveraging UCLA’s multidisciplinary strengths, the symposium will help define opportunities for integrated clinical care, research collaboration, innovation, and future program development.
Ultimately, this initiative aims to position UCLA to build a collaborative, specialized program that advances care for patients with these challenging diseases while strengthening opportunities for discovery, education, and national leadership.
Registration Fees
In-person & Virtual Attendance
- $100 Physicians
- $75 Allied Health Professionals
UC Recharge Payment Information
Registration payment can be submitted via the Interdepartmental or Intercampus recharge system.
For more details, please refer to document here: Recharge Information
Refunds
Cancellations must be received via email to the Center for Continuing Professional Development by Sunday, November 1, 2026 and will be subject to a $50 processing fee. No refunds will be granted after that date. David Geffen School of Medicine at UCLA reserves the right to cancel or postpone this course if necessary; in the event of cancellation, course fees will be fully refunded to the original form of payment. We are not responsible for other costs, such as non-refundable airline tickets or hotel penalties.
Course Recording
All registrants (live or virtual) will be provided the opportunity to review recorded sessions up to 3 weeks following the course.
The recorded sessions are not approved for Continuing Education (CE) credit.
Target Audience
Specialties - Nephrology, Rheumatology, Pulmonary Disease, Pathology, Family Medicine, Internal Medicine
Professions - Physician, Nurse Practitioner, Physician Assistant, Fellow/Resident, Nurse, Nurse Assistant, Pharmacist, Medical Student
Objectives
At the conclusion of this activity, learners will be able to:
- Recognize the clinical manifestations and diagnostic challenges of ANCA-associated vasculitis and C3 glomerulopathy to facilitate early diagnosis and timely referral.
- Explain the underlying immunologic and complement-mediated mechanisms of disease and their implications for diagnosis and targeted treatment
- Evaluate the efficacy, safety, and appropriate clinical use of novel therapies, including complement inhibitors, B-cell-directed therapies, and steroid-sparing treatment approaches.
- Apply current evidence-based guidelines and emerging clinical trial data to develop individualized treatment strategies for patients with ANCA-associated vasculitis and C3G
- Integrate multidisciplinary approaches involving nephrology, rheumatology, renal pathology, and transplant medicine to optimize patient outcomes
Accreditation
The David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The David Geffen School of Medicine at UCLA designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The California State Board of Registered Nursing accepts courses approved by the AMA PRA Category 1 Credits™ as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.
Related Events
